查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561493

2024-2032 年智慧药丸市场报告（按目标领域、疾病适应症、应用、最终用户和地区）

Smart Pills Market Report by Target Area, Disease Indication, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2023年全球智慧药丸IMARC Group规模达46亿美元。老年族群对慢性病管理的需求增加、技术的快速进步、微创手术（MIS）的新兴趋势、製药业对个人化医疗和药物输送的日益关注是推动市场的一些主要因素。

智慧药丸，也称为数位药丸或可摄入感测器，是一种创新药物，配备微型电子元件，可实现远端监控和资料收集。这些药丸通常包含感测器、微晶片和发射器，供患者服用。一旦进入体内，它们就会与体液相互作用，将有关患者健康指标、药物依从性和生理反应的即时资料发送到外部设备。医疗保健提供者和研究人员利用这些资料来加强患者护理、优化治疗计划和改善药物开发。智慧药丸透过增强监测和资料收集能力，为个人化医疗、慢性病管理和临床试验提供潜在好处。

在全球人口老化的推动下，全球智慧药丸市场正在经历大幅成长，导致慢性病盛行率增加，需要对患者的健康状况进行持续监测和管理。智慧药丸提供了一种非侵入性且有效的方式来收集即时健康资料，使其成为远端患者监测和疾病管理的宝贵工具。此外，微型电子和无线通讯技术的进步使得开发和生产智慧药丸更具成本效益，增加了医疗保健提供者和患者的可及性，这为市场扩张创造了积极的前景。除此之外，对个人化医疗的需求不断增长以及对精确药物输送系统的需求促使製药公司和研究人员投资智慧药丸技术，也促进了市场的成长。此外，COVID-19 大流行推动了远距医疗和远端监控解决方案的采用，进一步推动了智慧药丸市场的发展。

智慧药丸市场趋势/驱动因素：

人口老化与慢性病管理

一个重要的驱动因素是全球老年人口的增加。随着人口平均年龄的增加，糖尿病、高血压、心血管疾病等慢性疾病的盛行率也增加。管理这些状况通常需要持续监测和坚持用药。智慧药丸透过提供有关患者健康指标的非侵入性即时资料收集来提供创新的解决方案。这种远端监测功能对于难以采用传统监测方法的老年患者尤其有价值。医疗保健提供者可以利用智慧药丸的资料及时进行干预，调整治疗计划，并确保更好的疾病管理，从而提高老龄化人口的护理品质。

持续的技术进步

微型电子、感测器和无线通讯技术的进步极大地促进了智慧药丸市场的成长。这些技术进步促进了更小、更容易服用的智慧药丸的开发，提高了患者的舒适度和依从性，同时减少了服用过程中出现不适或阻力的可能性。此外，组件的小型化不仅降低了製造成本，还提高了智慧药丸的整体效率和寿命。因此，医疗保健提供者和患者受益于更容易获得和更具成本效益的解决方案，而智慧药丸收集的资料的准确性和可靠性得到了提高，在医学界得到了越来越多的认可，有助于市场扩张。

对个人化医疗和新型药物输送的需求不断增长

製药业对个人化医疗和精确药物输送系统日益增长的兴趣是另一个驱动因素。智慧药丸提供了一种将药物直接给药到体内目标部位的独特方法。这种标靶药物传递可以增强治疗效果，同时最大限度地减少副作用。製药公司越来越多地投资智慧药丸技术，作为改善药物开发的手段，确保药物适合个别患者的需求。除此之外，智慧药丸还可用于临床试验，收集药物效果的即时资料，简化研究过程，并有可能加快新疗法推向市场的速度。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球智慧药丸市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依目标区域

  • 食道
    • 市场趋势
    • 市场预测
  • 小肠
    • 市场趋势
    • 市场预测
  • 大肠
    • 市场趋势
    • 市场预测
  • 胃
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依疾病适应症

  • 食道疾病
    • 市场趋势
    • 市场预测
  • 小肠疾病
    • 市场趋势
    • 市场预测
  • 结肠疾病
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 胶囊内视镜
    • 市场趋势
    • 市场预测
  • 药物输送
    • 市场趋势
    • 市场预测
  • 病人监护
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 诊断中心
    • 市场趋势
    • 市场预测
  • 研究所
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • CapsoVision Inc.
    • Check-Cap Ltd.
    • General Electric Company
    • IntroMedic Co. Ltd.
    • Jinshan Science & Technology (Group) Co. Ltd.
    • Koninklijke Philips NV
    • Medtronic plc
    • Olympus Corporation
    • PENTAX Medical (Hoya Corporation)
Product Code: SR112024A4568

The global smart pills market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032. The increased demand for chronic disease management among the geriatric population, rapid technological advancements, emerging trend of minimally invasive surgeries (MIS), the increasing focus of pharmaceutical industry on personalized medicine and drug delivery are some of the major factors propelling the market.

Smart pills, also known as digital pills or ingestible sensors, are innovative pharmaceuticals equipped with tiny electronic components that enable remote monitoring and data collection. These pills typically contain sensors, microchips, and transmitters, which are ingested by patients. Once inside the body, they interact with bodily fluids, sending real-time data about a patient's health metrics, medication adherence, and physiological responses to external devices. Healthcare providers and researchers use this data to enhance patient care, optimize treatment plans, and improve drug development. Smart pills offer potential benefits in personalized medicine, chronic disease management, and clinical trials by enhancing monitoring and data acquisition capabilities.

The global smart pills market is experiencing substantial growth driven by the aging population across the globe has resulted in an increased prevalence of chronic diseases, requiring continuous monitoring and management of patient's health. Smart pills offer a non-invasive and efficient way to collect real-time health data, making them a valuable tool for remote patient monitoring and disease management. Moreover, advancements in miniaturized electronics and wireless communication technologies have made it more cost-effective to develop and produce smart pills, increasing their accessibility to healthcare providers and patients, which is creating a positive outlook for market expansion. In addition to this, the rising demand for personalized medicine and the need for precise drug delivery systems prompting pharmaceutical companies and researchers to invest in smart pill technology, are contributing to the market growth. Furthermore, the COVID-19 pandemic has fueled the adoption of telehealth and remote monitoring solutions, further boosting the market for smart pills.

Smart Pills Market Trends/Drivers:

Aging population and chronic disease management

One significant driver is the increasing geriatric population across the globe. As the average age of the population rises, so does the prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular diseases. Managing these conditions often requires continuous monitoring and medication adherence. Smart pills provide an innovative solution by offering non-invasive, real-time data collection on a patient's health metrics. This remote monitoring capability is particularly valuable for elderly patients who may have difficulty with conventional monitoring methods. Healthcare providers can use the data from smart pills to make timely interventions, adjust treatment plans, and ensure better disease management, improving the quality of care for aging populations.

Ongoing technological advancements

Advancements in miniaturized electronics, sensors, and wireless communication technologies have significantly contributed to the growth of the smart pills market. These technological strides have led to the development of smaller, more easily ingestible smart pills, enhancing patient comfort and compliance while reducing the potential for discomfort or resistance during ingestion. Moreover, the miniaturization of components has not only reduced manufacturing costs but also improved the overall efficiency and longevity of smart pills. As a result, healthcare providers and patients benefit from more accessible and cost-effective solutions, while the enhanced accuracy and reliability of the data collected by smart pills have garnered increased acceptance within the medical community, aiding in market expansion.

Growing demand for personalized medicine and novel drug delivery

The pharmaceutical industry's growing interest in personalized medicine and precise drug delivery systems is another driving factor. Smart pills offer a unique way to administer medications directly to the target site in the body. This targeted drug delivery can enhance the efficacy of treatments while minimizing side effects. Pharmaceutical companies are increasingly investing in smart pill technology as a means to improve drug development, ensuring that medications are tailored to individual patient needs. Apart from this, smart pills can be used in clinical trials to gather real-time data on the drug's effects, streamlining the research process and potentially speeding up the introduction of new therapies to the market.

Smart Pills Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on target area, disease indication, application and end user.

Breakup by Target Area:

  • Esophagus
  • Small Intestine
  • Large Intestine
  • Stomach

Small intestine dominate the market

The report has provided a detailed breakup and analysis of the market based on the target area. This includes esophagus, small intestine, large intestine, and stomach. According to the report, small intestine represented the largest segment.

The demand for smart pills targeting the small intestine is propelled by their unique ability to access and monitor this specific area of the digestive tract. The small intestine plays a crucial role in nutrient absorption, making it a focal point for various gastrointestinal disorders and drug delivery challenges. Smart pills designed to operate in this region offer precise insights into nutrient absorption efficiency, allowing for tailored dietary recommendations and treatments for conditions, such as malabsorption syndromes. Furthermore, their application extends to drug delivery optimization, ensuring medications reach the intended site of action, which is especially relevant for treatments that require absorption in the small intestine. As a result, the demand for smart pills tailored to the small intestine continues to rise, driven by their potential to address specific healthcare needs and enhance therapeutic outcomes.

Breakup by Disease Indication:

  • Esophageal Diseases
  • Small Bowel Diseases
  • Colon Diseases
  • Others

A detailed breakup and analysis of the market based on the disease indication have also been provided in the report. This includes esophageal diseases, small bowel diseases, colon diseases, and others.

The surging demand for smart pills in addressing esophageal, small bowel, and colon diseases owing to their capacity to provide precise, real-time data in these specific areas of the gastrointestinal tract is strengthening the market growth. Moreover, the growing prevalence of esophageal diseases such as gastroesophageal reflux disease (GERD), wherein smart pills help monitor pH levels and track acid reflux patterns, aiding in the diagnosis and management of these conditions. Apart from this, in small bowel diseases like Crohn's disease or celiac disease, these pills can help track the passage and transit time, enabling clinicians to assess motility and inflammation, while in colon diseases, particularly colorectal cancer screening, smart pills equipped with imaging capabilities can capture detailed images, enhancing early detection and reducing the need for invasive procedures. This targeted monitoring and diagnostic potential are propelling the demand for smart pills in the context of esophageal, small bowel, and colon diseases, improving patient care and outcomes.

Breakup by Application:

  • Capsule Endoscopy
  • Drug Delivery
  • Patient Monitoring

Capsule endoscopy dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes capsule endoscopy, drug delivery, and patient monitoring. According to the report, capsule endoscopy represented the largest segment.

Unlike traditional endoscopy, smart pills equipped with imaging technology provide a painless and patient-friendly alternative for visualizing the gastrointestinal tract. This has led to increased acceptance and patient compliance, especially in cases where traditional endoscopy may be uncomfortable or challenging. Additionally, capsule endoscopy using smart pills is particularly valuable for diagnosing and monitoring conditions such as obscure gastrointestinal bleeding, Crohn's disease, and small bowel tumors. The high-quality images and real-time data captured by these smart pills allow for early detection and precise localization of abnormalities, thereby facilitating timely interventions and improving patient outcomes. Consequently, the demand for smart pills in capsule endoscopy continues to grow, enhancing the diagnostic capabilities of healthcare professionals and patient experiences.

Breakup by End User:

  • Hospitals
  • Diagnostic Centers
  • Research Institutes

Diagnostic centers hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, diagnostic centers, and research institutes. According to the report, diagnostic centers accounted for the largest market share.

The rising demand for smart pills in diagnostic centers is bolstering market expansion by offering a patient-friendly, non-invasive approach to enhance diagnostic procedures. These devices provide real-time gastrointestinal data, aiding precise diagnoses, especially for conditions like gastrointestinal bleeding, motility disorders, and small bowel diseases. Smart pills' imaging capabilities, pH assessment, and transit monitoring provide clinicians with a comprehensive view of GI health, reducing the need for uncomfortable invasive procedures. This improves patient comfort, compliance, and diagnostic accuracy, benefiting both patients and healthcare providers, and contributing to the growing adoption of smart pills in diagnostic centers.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest smart pills market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's robust healthcare infrastructure, including advanced diagnostic centers and research institutions, is facilitating the adoption of smart pills for innovative diagnostic and research purposes. Concurrently, the increasing prevalence of gastrointestinal disorders, such as inflammatory bowel disease and colorectal cancer, has created a high demand for non-invasive diagnostic tools like smart pills, which offer improved patient comfort and compliance. Moreover, the region's aging population, with a growing need for chronic disease management, sees smart pills as an invaluable solution for remote patient monitoring. Besides this, favorable reimbursement policies and regulatory frameworks in North America are encouraging healthcare providers and pharmaceutical companies to invest in smart pill technology. Apart from this, the region's technological innovation and early market entry by leading companies have established a strong foundation for the growth of the North America smart pills market.

Competitive Landscape:

The global smart pills market presents a competitive landscape characterized by a mix of established players and emerging entrants striving to capitalize on the growing demand for remote patient monitoring and innovative healthcare solutions. Leading companies hold substantial market shares, primarily due to their early market entry, robust R&D capabilities, and extensive distribution networks. They offer a diverse range of smart pill products, incorporating advanced sensor technologies and data analytics platforms. Moreover, partnerships and collaborations with healthcare providers and pharmaceutical companies have further solidified their market position. At the same time, numerous startups and smaller companies, are actively contributing to market growth with disruptive technologies and novel applications of smart pills, intensifying competition and driving innovation in the industry.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • CapsoVision Inc
  • Check-Cap Ltd.
  • General Electric Company
  • IntroMedic Co. Ltd.
  • Jinshan Science & Technology (Group) Co. Ltd.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Olympus Corporation
  • PENTAX Medical (Hoya Corporation).

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

  • In 2020, CapsoVision Inc. (US) attained ISO 27001 security certification for both its headquarters and CapsoCloud software, reaffirming its unwavering dedication to safeguarding customer data.

Key Questions Answered in This Report:

  • How has the global smart pills market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global smart pills market?
  • What is the impact of each driver, restraint, and opportunity on the global smart pills market?
  • What are the key regional markets?
  • Which countries represent the most attractive smart pills market?
  • What is the breakup of the market based on the target area?
  • Which is the most attractive target area in the smart pills market?
  • What is the breakup of the market based on the disease indication?
  • Which is the most attractive disease indication in the smart pills market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the smart pills market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the smart pills market?
  • What is the competitive structure of the global smart pills market?
  • Who are the key players/companies in the global smart pills market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Smart Pills Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Target Area

  • 6.1 Esophagus
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Intestine
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Large Intestine
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Stomach
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Disease Indication

  • 7.1 Esophageal Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Small Bowel Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Colon Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Capsule Endoscopy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Delivery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Patient Monitoring
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 CapsoVision Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Check-Cap Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 General Electric Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 IntroMedic Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Jinshan Science & Technology (Group) Co. Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Koninklijke Philips N.V.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Olympus Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PENTAX Medical (Hoya Corporation)
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Smart Pills Market: Major Drivers and Challenges
  • Figure 2: Global: Smart Pills Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Smart Pills Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Smart Pills Market: Breakup by Target Area (in %), 2023
  • Figure 5: Global: Smart Pills Market: Breakup by Disease Indication (in %), 2023
  • Figure 6: Global: Smart Pills Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Smart Pills Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Smart Pills Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Smart Pills (Esophagus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Smart Pills (Esophagus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Smart Pills (Small Intestine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Smart Pills (Small Intestine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Smart Pills (Large Intestine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Smart Pills (Large Intestine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Smart Pills (Stomach) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Smart Pills (Stomach) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Smart Pills (Esophageal Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Smart Pills (Esophageal Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Smart Pills (Small Bowel Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Smart Pills (Small Bowel Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Smart Pills (Colon Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Smart Pills (Colon Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Smart Pills (Other Disease Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Smart Pills (Other Disease Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Smart Pills (Capsule Endoscopy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Smart Pills (Capsule Endoscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Smart Pills (Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Smart Pills (Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Smart Pills (Patient Monitoring) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Smart Pills (Patient Monitoring) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Smart Pills (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Smart Pills (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Smart Pills (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Smart Pills (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Smart Pills (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Smart Pills (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Smart Pills Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Smart Pills Industry: SWOT Analysis
  • Figure 87: Global: Smart Pills Industry: Value Chain Analysis
  • Figure 88: Global: Smart Pills Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Smart Pills Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Smart Pills Market Forecast: Breakup by Target Area (in Million US$), 2024-2032
  • Table 3: Global: Smart Pills Market Forecast: Breakup by Disease Indication (in Million US$), 2024-2032
  • Table 4: Global: Smart Pills Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Smart Pills Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Smart Pills Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Smart Pills Market: Competitive Structure
  • Table 8: Global: Smart Pills Market: Key Players